INTERNATIONAL PATENT: ONCOC4, INC., BIONTECH SE FILES APPLICATION FOR "ANTI-CTLA-4 ANTIBODY FOR TREATMENT OF PATIENTS WITH PROSTATE CANCER AND COMBINATION THERAPY WITH A RADIOLIGAND THERAPEUTIC AGENT"

GENEVA, July 2 -- ONCOC4, INC. (9640 Medical Center DriveRockville, Maryland 20850), BIONTECH SE (An der Goldgrube 1255131 Mainz) filed a patent application (PCT/EP2024/087999) for "ANTI-CTLA-4 ANTIBODY FOR TREATMENT OF PATIENTS WITH PROSTATE CANCER AND COMBINATION THERAPY WITH A RADIOLIGAND THERAPEUTIC AGENT" on Dec 20, 2024. With publication no. WO/2025/133186, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LIU, Yang (11516 Luvie CourtPotomac, MD 20854), ZHENG, Pan (11516 Luvie CourtPotomac, Maryland 20854), HO, Minh Q...